Morgan Brown Buys 15,000 Shares of CLNN as CFO

Morgan Brown, the Chief Financial Officer of CLNN, made a notable move by purchasing 15,000 shares of the company on June 11, 2026. The shares were acquired at no cost, reflecting an insider's confidence in the company's future.

Other Institutional Activity in CLNN

BOXER CAPITAL MANAGEMENT, LLC significantly increased its stake in CLNN by adding 277,778 shares, ending with 477,515 shares worth about $2.35 million. In contrast, SYMBIOSIS CAPITAL PARTNERS, LLC reduced its holdings by 339,401 shares, leaving it with 431,094 shares valued at approximately $2.13 million. VANGUARD CAPITAL MANAGEMENT LLC entered the scene with 308,230 shares, valued at about $1.52 million. SCOGGIN MANAGEMENT LP also increased its position by 25,000 shares, totaling 300,000 shares worth $1.48 million. Meanwhile, ENSIGN PEAK ADVISORS, INC boosted its holdings by 143,511 shares to 257,872 shares, valued at $1.27 million.

Insider Buying and Selling at Clene Inc.

In addition to Morgan Brown's purchase, several other insiders made significant buys on June 11, 2026. Mark Mortenson, the Chief Science Officer, bought 45,000 shares, while President & CEO Robert Dee Etherington acquired 65,000 shares. Earlier, on May 21, 2026, Shalom Jacobovitz, Arjun JJ Desai, and David Matlin also bought shares, with each purchasing between 3,658 and 5,159 shares.

Analysts Set New Price Targets

On May 4, 2026, HC Wainwright & Co. reiterated its 'buy' rating for CLNN with a price target of $31. D. Boral Capital also maintained its 'buy' rating, setting a target of $23 on the same day. Canaccord Genuity maintained its 'buy' stance with a higher target of $48 back on March 13, 2026. The consensus among analysts is a 'buy' recommendation, with an average target price reflecting optimism in the stock's potential.

Bottom Line

The insider buying activity at CLNN, led by CFO Morgan Brown, suggests a strong vote of confidence in the company's future. Institutional movements also indicate varied strategies among major players, with some increasing and others reducing their stakes. Analysts remain bullish, maintaining 'buy' ratings with targets suggesting substantial upside. As always, it's important to remember that insider transactions and analyst ratings are just pieces of the overall investment puzzle.